Goldman Sachs’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $116M | Buy |
2,105,605
+512,642
| +32% | +$28.2M | 0.02% | 689 |
|
2025
Q1 | $113M | Buy |
1,592,963
+1,083,512
| +213% | +$76.6M | 0.02% | 635 |
|
2024
Q4 | $33.5M | Buy |
509,451
+59,485
| +13% | +$3.91M | 0.01% | 1362 |
|
2024
Q3 | $31.6M | Sell |
449,966
-109,836
| -20% | -$7.72M | 0.01% | 1388 |
|
2024
Q2 | $46.1M | Sell |
559,802
-133,422
| -19% | -$11M | 0.01% | 1042 |
|
2024
Q1 | $60.5M | Sell |
693,224
-214,557
| -24% | -$18.7M | 0.01% | 893 |
|
2023
Q4 | $87.5M | Sell |
907,781
-71,814
| -7% | -$6.92M | 0.02% | 720 |
|
2023
Q3 | $86.7M | Sell |
979,595
-455,302
| -32% | -$40.3M | 0.02% | 680 |
|
2023
Q2 | $124M | Buy |
1,434,897
+306,018
| +27% | +$26.5M | 0.03% | 537 |
|
2023
Q1 | $110M | Sell |
1,128,879
-42,172
| -4% | -$4.1M | 0.03% | 571 |
|
2022
Q4 | $121M | Buy |
1,171,051
+388,026
| +50% | +$40.2M | 0.03% | 537 |
|
2022
Q3 | $66.4M | Sell |
783,025
-39,673
| -5% | -$3.36M | 0.02% | 799 |
|
2022
Q2 | $68.2M | Buy |
822,698
+114,080
| +16% | +$9.45M | 0.02% | 788 |
|
2022
Q1 | $54.6M | Sell |
708,618
-106,449
| -13% | -$8.21M | 0.01% | 1015 |
|
2021
Q4 | $72M | Sell |
815,067
-671,512
| -45% | -$59.3M | 0.01% | 875 |
|
2021
Q3 | $115M | Buy |
1,486,579
+235,441
| +19% | +$18.2M | 0.02% | 579 |
|
2021
Q2 | $104M | Buy |
1,251,138
+38,296
| +3% | +$3.2M | 0.02% | 616 |
|
2021
Q1 | $91.6M | Sell |
1,212,842
-393,128
| -24% | -$29.7M | 0.02% | 631 |
|
2020
Q4 | $141M | Sell |
1,605,970
-76,103
| -5% | -$6.67M | 0.04% | 391 |
|
2020
Q3 | $128M | Sell |
1,682,073
-226,417
| -12% | -$17.2M | 0.04% | 416 |
|
2020
Q2 | $235M | Buy |
1,908,490
+225,983
| +13% | +$27.9M | 0.07% | 229 |
|
2020
Q1 | $142M | Buy |
1,682,507
+69,790
| +4% | +$5.9M | 0.05% | 336 |
|
2019
Q4 | $136M | Buy |
1,612,717
+143,113
| +10% | +$12.1M | 0.03% | 499 |
|
2019
Q3 | $99.1M | Sell |
1,469,604
-498,011
| -25% | -$33.6M | 0.03% | 608 |
|
2019
Q2 | $169M | Sell |
1,967,615
-207,951
| -10% | -$17.8M | 0.05% | 404 |
|
2019
Q1 | $193M | Buy |
2,175,566
+146,363
| +7% | +$13M | 0.06% | 343 |
|
2018
Q4 | $173M | Sell |
2,029,203
-305,226
| -13% | -$26M | 0.06% | 334 |
|
2018
Q3 | $226M | Sell |
2,334,429
-407,815
| -15% | -$39.5M | 0.06% | 334 |
|
2018
Q2 | $258M | Sell |
2,742,244
-484,416
| -15% | -$45.6M | 0.07% | 271 |
|
2018
Q1 | $262M | Buy |
3,226,660
+361,158
| +13% | +$29.3M | 0.07% | 291 |
|
2017
Q4 | $256M | Buy |
2,865,502
+506,352
| +21% | +$45.2M | 0.06% | 312 |
|
2017
Q3 | $220M | Buy |
2,359,150
+395,081
| +20% | +$36.8M | 0.05% | 323 |
|
2017
Q2 | $178M | Buy |
1,964,069
+424,610
| +28% | +$38.6M | 0.05% | 398 |
|
2017
Q1 | $135M | Buy |
1,539,459
+158,527
| +11% | +$13.9M | 0.04% | 483 |
|
2016
Q4 | $114M | Buy |
1,380,932
+49,132
| +4% | +$4.07M | 0.03% | 561 |
|
2016
Q3 | $123M | Buy |
1,331,800
+641,098
| +93% | +$59.3M | 0.04% | 505 |
|
2016
Q2 | $53.7M | Sell |
690,702
-153,605
| -18% | -$12M | 0.02% | 869 |
|
2016
Q1 | $69.6M | Sell |
844,307
-221,233
| -21% | -$18.2M | 0.02% | 719 |
|
2015
Q4 | $112M | Buy |
1,065,540
+671,252
| +170% | +$70.3M | 0.04% | 491 |
|
2015
Q3 | $41.5M | Buy |
394,288
+140,873
| +56% | +$14.8M | 0.01% | 907 |
|
2015
Q2 | $34.7M | Sell |
253,415
-674,687
| -73% | -$92.3M | 0.01% | 1069 |
|
2015
Q1 | $116M | Buy |
928,102
+513,073
| +124% | +$63.9M | 0.04% | 456 |
|
2014
Q4 | $37.5M | Sell |
415,029
-37,405
| -8% | -$3.38M | 0.01% | 979 |
|
2014
Q3 | $32.6M | Sell |
452,434
-505,079
| -53% | -$36.4M | 0.01% | 1015 |
|
2014
Q2 | $59.6M | Buy |
957,513
+360,399
| +60% | +$22.4M | 0.02% | 734 |
|
2014
Q1 | $40.7M | Sell |
597,114
-129,842
| -18% | -$8.86M | 0.01% | 887 |
|
2013
Q4 | $51.1M | Sell |
726,956
-581,701
| -44% | -$40.9M | 0.02% | 747 |
|
2013
Q3 | $94.4M | Sell |
1,308,657
-101,098
| -7% | -$7.3M | 0.03% | 460 |
|
2013
Q2 | $78.6M | Buy |
+1,409,755
| New | +$78.6M | 0.03% | 479 |
|